# Iridex Corp (IRIX)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/iridex-corp/ JSON: https://steadybase.io/company/iridex-corp.json Checked Nov 10, 2026. Latest filing read: Aug 18, 2026.

## Company

- Legal name: IRIDEX CORP
- Ticker: IRIX (Nasdaq)
- SEC CIK: 0001006045
- Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Headquarters: Mountain View, CA
- Fiscal year ends: January 3
- SEC filer category: Non-accelerated filer<br>Smaller reporting company
- Website: iridex.com
- LinkedIn: https://www.linkedin.com/company/iridex
- Next earnings date: Nov 17, 2026

## Key facts

- Revenue: $52.7M for the fiscal year ended Jan 3, 2026 (10-K filed Apr 2, 2026). Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/0001193125-26-140194-index.html
- Operating income: -$2.6M for the fiscal year ended Jan 3, 2026 (10-K filed Apr 2, 2026). Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/0001193125-26-140194-index.html
- Net income: -$4.4M for the fiscal year ended Jan 3, 2026 (10-K filed Apr 2, 2026). Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/0001193125-26-140194-index.html
- SG&A: $18.1M for the fiscal year ended Jan 3, 2026 (10-K filed Apr 2, 2026). Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/0001193125-26-140194-index.html
- Employees: 93 as of Jan 3, 2026, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/irix-20260103.htm
- Shares outstanding: 17,564,912 as of Aug 13, 2026 (10-Q filed Aug 18, 2026). Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526355641/0001193125-26-355641-index.html
- Auditor: Bpm LLP, San Jose, California, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/irix-20260103.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Jan 3, 2026 | $52.7M | -$2.6M | -$4.4M | $18.1M |
| Dec 28, 2024 | $48.7M | -$8.3M | -$8.9M | $22.4M |
| Dec 30, 2023 | $51.9M | -$10.0M | -$9.6M | $25.0M |
| Dec 31, 2022 | $57.0M | -$7.5M | -$7.5M | $25.7M |
| Jan 1, 2022 | $53.9M | -$7.5M | -$5.2M | $23.5M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/iridex-corp.json

## Officers and directors

- Patrick Mercer, President and CEO. LinkedIn: https://linkedin.com/in/patrick-mercer-31babb7. Source: Form 4 filed Jul 14, 2026, https://www.sec.gov/Archives/edgar/data/1006045/000119312526303346/0001193125-26-303346-index.htm
- Romeo R. Dizon, Chief Financial Officer. Source: Form 4 filed Sep 16, 2026, https://www.sec.gov/Archives/edgar/data/1006045/000119312526393119/0001193125-26-393119-index.htm
- Scott Shuda, Chairperson of the Board. Source: 10-K filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/irix-20260103.htm
- Beverly A. Huss, Director. Source: 10-K filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/irix-20260103.htm
- Nick Chen, Director. Source: 10-K filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/irix-20260103.htm
- William Moore, Director. Source: 10-K filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/irix-20260103.htm
- Bassem BouHabib, Named in proxy. Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1006045/000207709626000092/ea0286869-03.htm
- Romeo Dizon, Named in proxy. Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1006045/000207709626000092/ea0286869-03.htm

## Recent 8-K events

- Sep 2, 2026: Item 3.01, Notice of delisting or failure to meet listing standards; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526380229/irix-20260827.htm
- Aug 18, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526355635/irix-20260818.htm
- Jul 16, 2026: Item 5.07, Submission of matters to a vote of security holders; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526305344/d101758d8k.htm
- Jun 18, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526275883/irix-20260612.htm
- May 19, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526230774/irix-20260519.htm
- Mar 26, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526126323/irix-20260326.htm
- Mar 13, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526106190/irix-20260309.htm
- Jan 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526009912/irix-20260112.htm
- Dec 11, 2025: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312525315298/irix-20251211.htm
- Nov 12, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312525277598/irix-20251111.htm

## Insider trades (Form 4)

- Sep 16, 2026: Romeo R. Dizon (Chief Financial Officer) bought 7,900 shares, about $4,977. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526393119/0001193125-26-393119-index.htm
- Sep 14, 2026: Romeo R. Dizon (Chief Financial Officer) bought 2,354 shares, about $1,530. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526390061/0001193125-26-390061-index.htm
- Sep 10, 2026: Romeo R. Dizon (Chief Financial Officer) bought 5,100 shares, about $3,468. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526387539/0001193125-26-387539-index.htm
- Aug 24, 2026: Romeo R. Dizon (Chief Financial Officer) bought 6,668 shares, about $5,001. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526362654/0001193125-26-362654-index.htm
- Jun 12, 2026: Romeo R. Dizon (Chief Financial Officer) bought 975 shares, about $1,112. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526270572/0001193125-26-270572-index.htm
- Jun 11, 2026: Romeo R. Dizon (Chief Financial Officer) bought 1,675 shares, about $1,909. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526269140/0001193125-26-269140-index.htm
- Jun 8, 2026: Romeo R. Dizon (Chief Financial Officer) bought 2,400 shares, about $2,688. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526263083/0001193125-26-263083-index.htm
- Jun 5, 2026: Romeo R. Dizon (Chief Financial Officer) bought 2,521 shares, about $2,899. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526260846/0001193125-26-260846-index.htm
- Jun 3, 2026: Romeo R. Dizon (Chief Financial Officer) bought 2,400 shares, about $2,808. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526255089/0001193125-26-255089-index.htm
- May 26, 2026: Romeo R. Dizon (Chief Financial Officer) bought 5,004 shares, about $5,004. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526238277/0001193125-26-238277-index.htm
- Mar 6, 2026: Romeo R. Dizon (Chief Financial Officer) bought 1,110 shares, about $1,399. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526098098/0001193125-26-098098-index.htm
- Feb 17, 2026: Romeo R. Dizon (Chief Financial Officer) bought 2,200 shares, about $2,942. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526054026/0001193125-26-054026-index.htm
- Feb 12, 2026: Romeo R. Dizon (Chief Financial Officer) bought 1,500 shares, about $2,145. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526047894/0001193125-26-047894-index.htm
- Feb 10, 2026: Romeo R. Dizon (Chief Financial Officer) bought 1,000 shares, about $1,460. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526044507/0001193125-26-044507-index.htm
- Feb 3, 2026: Romeo R. Dizon (Chief Financial Officer) bought 2,500 shares, about $3,450. Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526036078/0001193125-26-036078-index.htm

## What management said

- "Our second quarter results were highlighted by the continued momentum in our glaucoma business and operating positive cash flows" Patrick Mercer, President and CEO of Iridex (8-K filed Aug 18, 2026). Source: https://www.sec.gov/Archives/edgar/data/1006045/000119312526355635/irix-ex99_1.htm

## Latest filings

- 8-K filed Sep 2, 2026: https://www.sec.gov/Archives/edgar/data/1006045/000119312526380229/irix-20260827.htm
- 10-K filed Apr 2, 2026: https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/irix-20260103.htm
- 10-Q filed Aug 18, 2026: https://www.sec.gov/Archives/edgar/data/1006045/000119312526355641/irix-20260704.htm
- DEF 14A filed Apr 24, 2026: https://www.sec.gov/Archives/edgar/data/1006045/000207709626000092/ea0286869-03.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/